Ionis Pharmaceuticals | IONS - Ebitda


Ionis Pharmaceuticals reported $-157.12M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agios Pharmaceuticals USD -125.8M 20.45M Jun/2025
Alnylam Pharmaceuticals USD 381.78M 362.95M Sep/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Astellas Pharma JPY 151.7B 11.36B Sep/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Celltrion KRW 374.56B 352.67B Sep/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Divis Laboratories Ltd INR 8.88B 1.59B Sep/2025
Exelixis USD 248.93M 28.02M Sep/2025
Halozyme Therapeutics USD 248.25M 22.74M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Moderna USD -208M 552M Sep/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Neurocrine Biosciences USD 246.7M 93.8M Sep/2025
Novartis USD 5.88B 290M Sep/2025
OPKO Health USD 75.53M 144.7M Sep/2025
Organigram Holdings CAD 6.15M 455K Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Pharma Mar EUR -1.98M 28.13M Sep/2025
PTC Therapeutics USD -33.11M 1B Jun/2025
Qiagen NV USD 193.17M 15.81M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Sartorius EUR 277.4M 30.5M Dec/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Ultragenyx Pharmaceutical USD -91.34M 35.09M Jun/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025